Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-omics Combined With Clinical Data Analysis to Identify Prognostic Biomarkers of Lung Cancer

NCT05010330 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT05010330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05010330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-omics Combined With Clinical Data Analysis to Identify Prognostic Biomarkers of Lung Cancer
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2020
Completion date
September 30, 2021
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung adenocarcinoma, lung cancer, lung squamous cell carcinoma, non small cell lung cancer